NX PharmaGen
NX PharmaGen’s business model is to acquire, develop, and monetize mature clinical-stage breakthrough technologies. The company’s lead program is a disruptive diagnostic technology, termed the NeXosomeTM Platform, which is designed to yield.
BioTech
Louisville, KY
$1M-10M
Funding
11-50
Employees
Looking for a better job?
Discover the best career opportunities with the best company cultures for you.
Do you work at this company?
Connect your business to thousands of engaged professionals in your city and beyond.
